These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 26872119)

  • 1. A Case Report of Camptocormia Coinciding With Olanzapine Use.
    González-Pablos E; Valles-de la Calle JM; Iglesias-Santa Polonia F; Cámara Barrio S
    J Clin Psychopharmacol; 2016 Apr; 36(2):183-4. PubMed ID: 26872119
    [No Abstract]   [Full Text] [Related]  

  • 2. [Camptocormia and pleurothotonus: rare side effects of neuroleptics].
    Olsson H
    Lakartidningen; 2014 Feb 19-25; 111(8):337-9. PubMed ID: 24669454
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug-induced camptocormia: a lesson regarding vascular Parkinsonism.
    Nakayama Y; Miwa H
    Intern Med; 2012; 51(19):2843-4. PubMed ID: 23037490
    [No Abstract]   [Full Text] [Related]  

  • 4. Camptocormia: case presentation.
    Tejera B; Holgado S; Calderón V; Pérez R
    Reumatol Clin; 2013; 9(3):195-6. PubMed ID: 22771271
    [No Abstract]   [Full Text] [Related]  

  • 5. Herbal medicine (Shakuyaku-kanzo-to) improves olanzapine-associated hyperprolactinemia: a case report.
    Hori H; Yoshimura R; Katsuki A; Nakamura J
    J Clin Psychopharmacol; 2013 Feb; 33(1):122-3. PubMed ID: 23288231
    [No Abstract]   [Full Text] [Related]  

  • 6. Persistent camptocormia associated with atomoxetine in a child with attention-deficit/hyperactivity disorder.
    Bhattacharya A; Praharaj SK; Sinha VK
    J Child Adolesc Psychopharmacol; 2014 Dec; 24(10):596-7. PubMed ID: 25469421
    [No Abstract]   [Full Text] [Related]  

  • 7. Camptocormia and Antipsychotic Medications.
    Subhedar R; Perugula ML; Shah K; Mansuri Z; Jain S
    Prim Care Companion CNS Disord; 2024 May; 26(3):. PubMed ID: 38815273
    [No Abstract]   [Full Text] [Related]  

  • 8. MRI findings in camptocormia.
    Gillardin P; Lemmerling M; Van der Linden C
    Acta Neurol Belg; 2014 Dec; 114(4):315-7. PubMed ID: 24638857
    [No Abstract]   [Full Text] [Related]  

  • 9. Camptocormia Induced by a Dopaminergic Agonist.
    Mano T
    Clin Neuropharmacol; 2018; 41(2):70-72. PubMed ID: 29401068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risperidone alternative for a schizophrenic patient with olanzapine-exacerbated diabetic mellitus.
    Wu PL; Lane HY; Su KP
    Psychiatry Clin Neurosci; 2006 Feb; 60(1):115-6. PubMed ID: 16472369
    [No Abstract]   [Full Text] [Related]  

  • 11. Facial edema with olanzapine.
    Malhotra M; Shrivastava MK
    Gen Hosp Psychiatry; 2013; 35(6):682.e7-8. PubMed ID: 23993413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Olanzapine-induced acute rhabdomyolysis-a case report.
    Baumgart U; Schmid R; Spiessl H
    Pharmacopsychiatry; 2005 Jan; 38(1):36-7. PubMed ID: 15706465
    [No Abstract]   [Full Text] [Related]  

  • 13. Camptocormia as an onset symptom of myasthenia gravis.
    Sato T; Natori T; Hata T; Yamashiro N; Shindo K; Takiyama Y
    Neurol Sci; 2017 Mar; 38(3):515-516. PubMed ID: 27812759
    [No Abstract]   [Full Text] [Related]  

  • 14. Isolated camptocormia revealing sporadic late onset nemaline myopathy.
    Kemta Lekpa F; Chevalier X; Dubourg O; Dimitri D
    Presse Med; 2013; 42(7-8):1142-4. PubMed ID: 23498645
    [No Abstract]   [Full Text] [Related]  

  • 15. Olanzapine-induced neuroleptic malignant syndrome in a patient with paranoid schizophrenia.
    Srivastava A; Borkar HA; Chandak S
    Psychiatry Clin Neurosci; 2009 Feb; 63(1):119-21. PubMed ID: 19067992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Camptocormia as presenting sign in dementia with Lewy bodies.
    Gavrylova N; Limousin N; Belin J; de Toffol B; Praline J
    Clin Neurol Neurosurg; 2013 Nov; 115(11):2397-8. PubMed ID: 24099692
    [No Abstract]   [Full Text] [Related]  

  • 17. Severe hypertriglyceridemia associated with olanzapine.
    Stoner SC; Dubisar BM; Khan R; Farrar CD
    J Clin Psychiatry; 2002 Oct; 63(10):948-9. PubMed ID: 12416606
    [No Abstract]   [Full Text] [Related]  

  • 18. Olanzapine-induced neuroleptic malignant syndrome after 10 years of treatment.
    Oglodek E; Szota A; Araszkiewicz A
    Aust N Z J Psychiatry; 2013 Oct; 47(10):972. PubMed ID: 23630396
    [No Abstract]   [Full Text] [Related]  

  • 19. Liver toxicity due to olanzapine.
    Domínguez-Jiménez JL; Puente-Gutiérrez JJ; Pelado-García EM; Cuesta-Cubillas D; García-Moreno AM
    Rev Esp Enferm Dig; 2012 Dec; 104(11):617-8. PubMed ID: 23368661
    [No Abstract]   [Full Text] [Related]  

  • 20. Variant ataxia-telangiectasia with prominent camptocormia.
    Paucar M; Schechtmann G; Taylor AM; Svenningsson P
    Parkinsonism Relat Disord; 2019 May; 62():253-255. PubMed ID: 30579816
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.